You are viewing the site in preview mode

Skip to main content


Fig. 5 | BMC Infectious Diseases

Fig. 5

From: Antiretroviral resistance in HIV-1 patients at a tertiary medical institute in Saudi Arabia: a retrospective study and analysis

Fig. 5

Comparison of the resistance causing mutations reported internationally and at KFSH&RC in the PI’s (Protease inhibitors) combinations. The Blue ribbon represents the World Reported mutations, while the Pink ribbons are the mutations reported at KFSH& RC reported mutations. Bold letter represents the world Reported mutations but with a different drug at KFSH&RC (different profile of mutations), while the Red represents the Novel mutations which were never previously reported

Back to article page